Benjamin OshrineMedical Director at Immunogen, USASpeaker
Agenda Sessions
Pivekimab Sunirine (IMGN632): A Next-Generation ADC for CD123+ Hematologic Malignancies
, 10:35View Session
Pivekimab Sunirine (IMGN632): A Next-Generation ADC for CD123+ Hematologic Malignancies